<DOC>
	<DOC>NCT02727270</DOC>
	<brief_summary>The objective of this study is to evaluate the cortisol awakening response with persons with PD and moderate levels of stress as compared to controls and persons with PD and low levels of stress. These data are desired so experience can be gained with measuring stress levels subjectively and objectively in persons with PD.</brief_summary>
	<brief_title>Measuring Cortisol Levels in Persons With Parkinson's (PD)</brief_title>
	<detailed_description>Telephone consent will be obtained. Participants will collect saliva at twelve time points - (four times a day for three days prior to their in-person visit). Participants will then have a half-hour in-person visit at the VA to assess stress, mood, quality of life, and Parkinson's.</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Group (1) Inclusion: PD as confirmed by NINDS criteria PD confirmed by a movement disorders specialist a Perceived Stress Scale (PSS) score higher than or equal to 13. Group (2) Inclusion: PD as confirmed by NINDS criteria PD confirmed by a movement disorders specialist PSS score lower than 13. Group (3) Inclusion: No significant neurological disorder PSS score of less than 13. The use of medications known to effect cortisol levels (estrogen, synthetic glucocorticoids, androgens, phenytoin, spironolactone, prednisone, prednisolone, and hydrocortisone).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Movement disorders</keyword>
	<keyword>Metabolic Stress</keyword>
</DOC>